UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058836
Receipt number R000067278
Scientific Title Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion: a randomized, double blind, placebo-controlled study
Date of disclosure of the study information 2025/08/20
Last modified on 2025/08/19 13:27:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion.

Acronym

RES study

Scientific Title

Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion: a randomized, double blind, placebo-controlled study

Scientific Title:Acronym

Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the effects of wearing test products on concentration and physical range of motion

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concentration Assessment Test, measurement of physical range of motion

Key secondary outcomes

subjective evaluation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

For concentration assessment, the hat-type device (test product) was worn once, and for range of motion assessment, the ankle band-type device (test product) was worn for two weeks.

Interventions/Control_2

For concentration assessment, the hat-type device (placebo) was worn once, and for range of motion assessment, the ankle band-type device (placebo) was worn for two weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Subjects who suffer from fatigue, stiff shoulders, or lower back pain
2.Subjects who feel a decline in concentration or find it difficult to focus

Key exclusion criteria

1. Subjects with a history of treatment that may have affected the test site.
2. Subjects with color vision deficiency (reduced color perception).
3. Subjects unable to wash the test product.
4. Subjects who have started taking a new medication within the past two months.
5. Subjects currently attending chiropractic clinics, gyms, or yoga classes.
6. Subjects planning to change their lifestyle during the study period.
7. Subjects who have participated in or plan to participate in other clinical trials within the past month prior to consent acquisition.
8. Subjects who are currently pregnant or breastfeeding (including those who have recently given birth).
9. Subjects with alcoholism or heavy smokers.
10. Subjects with a history of food or contact allergies.
11. Subjects receiving hormone replacement therapy.
12. Subjects unable to walk independently without assistance.
13. Subjects suspected of mild or severe dementia.
14. Subjects deemed inappropriate by the principal investigator.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Email

info@yakujihou.org


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Kaneko

Organization

Japan Clinical Trial Association

Division name

N.A.

Zip code

1600022

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

TEL

0364574666

Homepage URL


Email

info@yakujihou.org


Sponsor or person

Institute

Japan Clinical Trial Association

Institute

Department

Personal name



Funding Source

Organization

Relive Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Pharmaceutical Law Wisdoms

Address

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

Tel

0364574911

Email

master@yakujihou.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 01 Day

Date of IRB

2025 Year 07 Month 10 Day

Anticipated trial start date

2025 Year 08 Month 20 Day

Last follow-up date

2025 Year 09 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 19 Day

Last modified on

2025 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067278